医学
卵巢癌
输卵管
输卵管癌
癌症
妇科
肿瘤科
疾病
内科学
作者
Joyce F. Liu,Andrew Berchuck,Floor J. Backes,Joshua G. Cohen,Rachel N. Grisham,Charles A. Leath,Lainie P. Martin,Daniela Matei,David S. Miller,Sharon E. Robertson,Lisa Barroilhet,Shitanshu Uppal,Andrea Wahner Hendrickson,David M. Gershenson,Heidi J. Gray,Ardeshir Hakam,Angela Jain,Gottfried E. Konecny,John W. Moroney,Elena Ratner
出处
期刊：Journal of The National Comprehensive Cancer Network
日期：2024-10-01
卷期号：22 (8): 512-519
被引量：7
标识
DOI：10.6004/jnccn.2024.0052
摘要
The NCCN Guidelines for Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer provide multidisciplinary diagnostic workup, staging, and treatment recommendations for this disease. These NCCN Guidelines Insights detail how the evolution of the use of PARP inhibitors as maintenance and single-agent regimens for the treatment of ovarian cancer informed panel recommendations in the guidelines.
科研通智能强力驱动
Strongly Powered by AbleSci AI
cdercder
余味
剑指东方是为谁
赫枫
高大凌寒
bc
Thien
平常的毛豆
遇上就这样吧
非而者厚
yufanhui
andrele
VDC
昏睡的蟠桃
核桃
飘零无边
back you up
Singularity
机灵柚子
MchemG
皖公网安备34019202002308
